Small intestinal bacterial overgrowth and Helicobacter pylori: can they be cause of thrombocytopenia in patients with chronic liver disease?

MeSH terms

• Anti-Infective Agents / therapeutic use
• Chronic Disease
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Female
• Follow-Up Studies
• Helicobacter Infections / complications
• Helicobacter Infections / diagnosis
• Helicobacter Infections / drug therapy*
• Helicobacter pylori / drug effects
• Helicobacter pylori / growth & development*
• Humans
• Intestine, Small / drug effects
• Intestine, Small / microbiology
• Liver Cirrhosis / complications
• Liver Cirrhosis / drug therapy*
• Liver Cirrhosis / pathology
• Male
• Rifamycins / therapeutic use*
• Rifaximin
• Risk Assessment
• Thrombocytopenia / etiology*
• Thrombocytopenia / physiopathology
• Treatment Outcome